Miguel Valle1, Rosario Martos2, María Dolores Cañete3, Rosario Valle4, Eva L van Donkelaar5, Francisco Bermudo1, Ramón Cañete6,7. 1. Clinical Laboratory Department, Valle de los Pedroches Hospital, Pozoblanco, Córdoba, Spain. 2. Health Center of Pozoblanco, IMIBIC Córdoba, Spain. 3. PAIDI Group TSH-329 (IMIBIC), University of Cordoba, Córdoba, Spain. 4. Faculty of Medicine, Medical Surgical Specialties Department, Córdoba, Spain. 5. Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. 6. Pediatric Department, Reina Sofía Hospital, School of Medicine Córdoba, Córdoba, Spain. 7. School of Medicine Córdoba, Córdoba, Spain.
Abstract
BACKGROUND: High serum uric acid (SUA) levels are present in patients with metabolic syndrome (MetS), when the latter is associated with endothelial dysfunction, inflammation, and hypertension. This increase in SUA levels may have a key role in cardiovascular diseases. OBJECTIVE: We aim to quantify the differences in inflammation biomarkers, endothelial dysfunction, and parameters associated with MetS in obese prepubertal children compared to non-obese children, and determine if there is a relationship between uric acid levels and these variables. METHODS: A cross-sectional study was carried out on obese children (6-9 yr old). The study included 43 obese children and the same number of non-obese children (control group), matched by age and sex. SUA, C-reactive protein (CRP), interleukin-6 (IL-6), soluble intercellular adhesion molecule-1 (sICAM-1), glucose, insulin, lipid profile, and blood pressure were all measured. RESULTS: SUA levels, CRP, and sICAM-1 were significantly higher in obese children. In the obese group, SUA levels showed a positive correlation with body mass index (BMI), insulin, homeostasis model assessment for insulin resistance (HOMA-IR), CRP, IL-6, sICAM-1, and triglycerides (TGs), and correlated negatively with high-density lipoprotein cholesterol (HDL-C) and Apo-AI, but not with Apo-B. When adjusted for age, sex, and creatinine, it was noted that SUA levels are independent predictive factors for sICAM-1, CRP, and IL-6. CONCLUSIONS: Inflammation biomarkers, endothelial dysfunction, and parameters associated with MetS are elevated in obese prepubertal children and correlate to uric acid levels.
BACKGROUND: High serum uric acid (SUA) levels are present in patients with metabolic syndrome (MetS), when the latter is associated with endothelial dysfunction, inflammation, and hypertension. This increase in SUA levels may have a key role in cardiovascular diseases. OBJECTIVE: We aim to quantify the differences in inflammation biomarkers, endothelial dysfunction, and parameters associated with MetS in obese prepubertal children compared to non-obesechildren, and determine if there is a relationship between uric acid levels and these variables. METHODS: A cross-sectional study was carried out on obesechildren (6-9 yr old). The study included 43 obesechildren and the same number of non-obesechildren (control group), matched by age and sex. SUA, C-reactive protein (CRP), interleukin-6 (IL-6), soluble intercellular adhesion molecule-1 (sICAM-1), glucose, insulin, lipid profile, and blood pressure were all measured. RESULTS:SUA levels, CRP, and sICAM-1 were significantly higher in obesechildren. In the obese group, SUA levels showed a positive correlation with body mass index (BMI), insulin, homeostasis model assessment for insulin resistance (HOMA-IR), CRP, IL-6, sICAM-1, and triglycerides (TGs), and correlated negatively with high-density lipoprotein cholesterol (HDL-C) and Apo-AI, but not with Apo-B. When adjusted for age, sex, and creatinine, it was noted that SUA levels are independent predictive factors for sICAM-1, CRP, and IL-6. CONCLUSIONS:Inflammation biomarkers, endothelial dysfunction, and parameters associated with MetS are elevated in obese prepubertal children and correlate to uric acid levels.
Authors: Emin Murat Akbas; Aysu Timuroglu; Adalet Ozcicek; Fatih Ozcicek; Levent Demirtas; Adem Gungor; Nergis Akbas Journal: Int J Clin Exp Med Date: 2014-12-15
Authors: Mauricio Andrés Salinas-Santander; Rafael Baltazar León-Cachón; Ana Cecilia Cepeda-Nieto; Celia Nohemí Sánchez-Domínguez; María Antonia González-Zavala; Hugo Leonid Gallardo-Blanco; Sandra Cecilia Esparza-González; Miguel Ángel González-Madrazo Journal: Biomed Rep Date: 2015-10-27
Authors: Thaís da Silva Ferreira; Julia Freitas Rodrigues Fernandes; Luciene da Silva Araújo; Lívia de Paula Nogueira; Priscila Mansur Leal; Vanessa Parada Antunes; Maria de Lourdes Guimarães Rodrigues; Debora Cristina Torres Valença; Sergio Emanuel Kaiser; Márcia Regina Simas Torres Klein Journal: Arq Bras Cardiol Date: 2018-10-11 Impact factor: 2.000
Authors: Piotr Skrzypczyk; Anna Ozimek; Anna Ofiara; Michał Szyszka; Jarosław Sołtyski; Anna Stelmaszczyk-Emmel; Elżbieta Górska; Małgorzata Pańczyk-Tomaszewska Journal: Cent Eur J Immunol Date: 2019-09-30 Impact factor: 2.085